NCT05253911 2025-12-04
TRACE
iOMEDICO AG
Completed
Clinical Trials
6 trialsNCT06833268 2025-07-08
Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan
Daiichi Sankyo
Completed
NCT05149014 2024-09-26
Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
Daiichi Sankyo France
Completed
NCT05458401 2024-03-15
EUROPA T-DXd
Daiichi Sankyo
Completed
NCT05769751 2023-08-16
A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer
Daiichi Sankyo
Completed
NCT04756921 2021-02-16
18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response
Fudan University
Completed